Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Yen‐Fu Chen

ResearcherPublications, citations & collaboration network

Yen‐Fu Chen is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 377 works, 9,124 citations, an h-index of 46 and an i10-index of 125.

377
Works
9,124
Citations
46
h-index
125
i10-index

How has Yen‐Fu Chen's publication output changed over time?

ScholarIQpublication output · 1996–2020

Output grew100% over the shown period — from 1 works in 1996 to 2 in 2020.

1
1
1
2
1
1
2
2
19962005200820112013201420162020

What are the most-cited papers on Yen‐Fu Chen?

ScholarIQmost cited works
The systemic immune response to trauma: an overview of pathophysiology and treatment
Janet M. Lord, Mark J. Midwinter, Yen‐Fu Chen, Antonio Belli, Karim Brohi, Elizabeth J. Kovacs, Leo Koenderman, Paul Kubes, Richard Lilford
The Lancet. 2014842 CitationsOPEN ACCESS
The history, geography, and sociology of slums and the health problems of people who live in slums
Alex Ezeh, Oyinlola Oyebode, David Satterthwaite, Yen‐Fu Chen, Robert Ndugwa, Jo Sartori, Blessing Mberu, G. J. Meléndez‐Torres, Tilahun Haregu, Sam Watson, Waleska Teixeira Caiaffa, Anthony Capon, Richard Lilford
The Lancet. 2016795 CitationsOPEN ACCESS
iGEMDOCK: a graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysis
Kai‐Cheng Hsu, Yen‐Fu Chen, Shen-Rong Lin, Jinn‐Moon Yang
S19032547. 2011528 CitationsOPEN ACCESS
Impact of the societal response to COVID-19 on access to healthcare for non-COVID-19 health issues in slum communities of Bangladesh, Kenya, Nigeria and Pakistan: results of pre-COVID and COVID-19 lockdown stakeholder engagements
Syed Ahsanuddin Ahmed, Motunrayo Ajisola, Kehkashan Azeem, Pauline Bakibinga, Yen‐Fu Chen, Nazratun Nayeem Choudhury, Olufunke Fayehun, Frances Griffiths, Bronwyn Harris, Peter Kibe, Richard Lilford, Akinyinka Omigbodun, Narjis Rizvi, Jo Sartori, Simon Smith, Sam Watson, Ria Wilson, Godwin Yeboah, Navneet Aujla, Iqbal Azam, Peter J. Diggle, Paramjit Gill, Romaina Iqbal, Caroline Kabaria, Lyagamula Kisia, Catherine Kyobutungi, Jason Madan, Blessing Mberu, Shukri F. Mohamed, Ahsana Nazish, Oladoyin Odubanjo, Mary E. Osuh, Eme Owoaje, Oyinlola Oyebode, João Porto de Albuquerque, Omar Rahman, Komal Tabani, Olalekan John Taiwo, Grant Tregonning, Olalekan A. Uthman, Rita Yusuf
BMJ Global Health. 2020383 CitationsOPEN ACCESS
Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation
Yen‐Fu Chen, Paresh Jobanputra, Pelham Barton, Sara E. Bryan, A Fry-Smith, Gerald J. Harris, Robert Taylor
Health Technology Assessment. 2008338 CitationsOPEN ACCESS

Related on ScholarIQ

National Yang Ming Chiao Tung University
Institution
The systemic immune response to trauma: an overview of pathophysiology and treatment
Paper
The history, geography, and sociology of slums and the health problems of people who live in slums
Paper
iGEMDOCK: a graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysis
Paper
Impact of the societal response to COVID-19 on access to healthcare for non-COVID-19 health issues in slum communities of Bangladesh, Kenya, Nigeria and Pakistan: results of pre-COVID and COVID-19 lockdown stakeholder engagements
Paper
Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation
Paper
470M+ articles · free account